Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease

Tohoku Journal of Experimental Medicine

Volumn 228, Issue 3, 2012, Pages 189-196

  Gezen Ak, Duygu ^a   Dursun, Erdinç ^a   Bilgiç, Başar ^b   Hanaǧasi, Haşmet ^b   Ertan, Turan ^a   Gürvit, Hakan ^b   Emre, Murat ^b   Eker, Engin ^a   Ulutin, Turgut ^a   Uysal, Ömer ^c   Yilmazer, Selma ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Alzheimer's disease; Haplotype; Neurodegeneration; Vitamin D; Vitamin D receptor

Indexed keywords

VITAMIN D RECEPTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; ONSET AGE; POLYMERASE CHAIN REACTION; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; VITAMIN D RECEPTOR GENE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; DNA PRIMERS; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL;

EID: 84867850716     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.228.189     Document Type: Article

References (52)

1. Annweiler, C., Fantino, B., Parot-Schinkel, E., Thiery, S., Gautier, J. & Beauchet, O. (2011) Alzheimer's disease-input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial. Trials, 12, 230.
2. Annweiler, C., Fantino, B., Schott, A.M., Krolak-Salmon, P., Allali, G. & Beauchet, O. (2012a) Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur. J. Neurol., 19, 1023-1029.
3. Annweiler, C., Rolland, Y., Schott, A.M., Blain, H., Vellas, B. & Beauchet, O. (2012b) Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement. Geriatr. Cogn. Disord., 32, 273-278.
4. Annweiler, C., Schott, A.M., Allali, G., Bridenbaugh, S.A., Kressig, R.W., Allain, P., Herrmann, F.R. & Beauchet, O. (2010) Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology, 74, 27-32.
5. Beecham, G.W., Martin, E.R., Li, Y.J., Slifer, M.A., Gilbert, J.R., Haines, J.L. & Pericak-Vance, M.A. (2009) Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. Am. J. Hum. Genet., 84, 35-43.
6. Beydoun, M.A., Ding, E.L., Beydoun, H.A., Tanaka, T., Ferrucci, L. & Zonderman, A.B. (2012) Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am. J. Clin. Nutr., 95, 163-178.
7. Blacker, D., Wilcox, M.A., Laird, N.M., Rodes, L., Horvath, S.M., Go, R.C., Perry, R., Watson, B. Jr., Bassett, S.S., McInnis, M.G., Albert, M.S., Hyman, B.T. & Tanzi, R.E. (1998) Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet., 19, 357-360.
8. Burkert, R., McGrath, J. & Eyles, D. (2003) Vitamin D receptor expression in the embryonic rat brain. Neurosci. Res. Commun., 33, 63-71.
9. Butler, M.W., Burt, A., Edwards, T.L., Zuchner, S., Scott, W.K., Martin, E.R., Vance, J.M. & Wang, L. (2011) Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann. Hum. Genet., 75, 201-210.
10. Cekic, M., Sayeed, I. & Stein, D.G. (2009) Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and Disease. Front. Neuroendocrin., 30, 158-172.
11. Chabas, J.F., Alluin, O., Rao, G., Garcia, S., Lavaut, M. N, Risso, J. J, Legre, R., Magalon, G., Khrestchatisky, M., Marqueste, T., Decherchi, P. & Feron, F. (2008) Vitamin D2 potentiates axon regeneration. J. Neurotrauma, 25, 1247-1256.
12. Cherniack, E.P., Florez, H., Roos, B.A., Troen, B.R. & Levis, S. (2008) Hypovitaminosis D in the elderly: from bone to brain. J. Nutr. Health Aging, 12, 366-373.
13. Dickens, A.P., Lang, I.A., Langa, K.M., Kos, K. & Llewellyn, D.J. (2011) Vitamin D, cognitive Dysfunction and Dementia in older adults. CNS Drugs, 25, 629-639.
14. Dursun, E., Gezen-Ak, D. & Yilmazer, S. (2011) A novel perspective for Alzheimer's disease: vitamin D receptor suppression by Amyloid-β and preventing the Amyloid-β induced alterations by vitamin D in cortical neurons. J. Alzheimers Dis., 23, 207-219.
15. Elaroussi, M.A., Prahl, J.M. & DeLuca, H.F. (1994) The avian vitamin D receptors: primary structures and their origins. Proc. Natl. Acad. Sci. USA, 91, 11596-11600.
16. Emilien, G., Durlach, C., Minaker, K.L., Winblad, B., Gauthier, S. & Maloteaux, J.M. (2004) Introduction. In Alzheimer Disease Neuropsychology and Pharmacology. 1st ed., Birkghauser Verlag, Basel, pp. x-xxiv.
17. Evatt, M.L., DeLong, M.R., Khazai, N., Rosen, A., Triche, S. & Tangpricha, V. (2008) Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch. Neurol., 65, 1348-1352.
18. Eyles, D.W., Smith, S., Kinobe, R., Hewison, M. & McGrath, J.J. (2005) Distribution of the vitamin D receptor and 1 alphahydroxylase in human brain. J. Chem. Neuroanat., 29, 21-30.
19. Féron, F., Burne, T.H. J, Brown, J., Smith, E., McGrath, J. J, Mackay-Sim, A. & Eyles, D.W. (2005) Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res. Bull., 65, 141-148.
20. Fiala, M. & Mizwicki, M.T. (2011) Neuroprotective and immune effects of active forms of vitamin D3 and docosahexaenoic acid in Alzheimer disease patients. Functional Foods in Health and Disease, 12, 545-554.
21. Freedman, L.P., Arce, V. & Perez Fernandez, R. (1994) DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor. Mol Endocrinol, 8, 265-273.
22. Garcion, E., Wion-Barbot, N., Montero-Menei, C.N., Berger, F. & Wion, D. (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab., 13, 100-105.
23. Gezen-Ak, D., Dursun, E., Ertan, T., Hanagasi, H., Gurvit, H., Emre, M., Eker, E., Ozturk, M., Engin, F. & Yilmazer, S. (2007) Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J. Exp. Med., 212, 275-282.
24. Gezen-Ak, D., Dursun, E. & Yilmazer, S. (2011) The effects of vitamin D receptor silencing on the expression of LVSCCA1C and LVSCC-A1D and the release of NGF in cortical neurons. PLos One, 6: e17553.
25. Hardy, J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci., 20, 154-159.
26. Holick, M.F. (1995) Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone, 17, 107s-111s.
27. Hollenbach, E., Ackermann, S., Hyman, B.T. & Rebeck, G.W. (1998) Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology, 50, 1905-1907.
28. Issa, L.L., Leong, G.M. & Eisman, J.A. (1997) Molecular mechanism of vitamin D receptor action. Inflamm. Res., 47, 451-475.
29. Johnson, J.A., Grande, J.P., Windebank, A.J. & Kumar, R. (1996) 1,25-Dihydroxyvitamin D(3) receptors in developing dorsal root ganglia of fetal rats. Brain Res. Dev. Brain Res., 92, 120-124.
30. Keisala, T., Minasyan, A., Lou, Y.R., Zou, J., Kalueff, A.V., Pyykkö, I. & Tuohimaa, P. (2009) Premature aging in vitamin D receptor mutant mice. J. Steroid Biochem. Mol. Biol., 115, 91-97.
31. Kiraly, S.J., Kiraly, M.A., Hawe, R.D. & Makhani, N. (2006) Vitamin D as a neuroactive substance: review. Scientific World Journal, 6, 125-139.
32. Kuningas, M., Mooijaart, S.P., Jolles, J., Slagboom, P.E., Westendorp, R.G.J. & van Heemst, D. (2009) VDR gene variants associate with cognitive function and depressive symptoms in old age. Neurobiol. Aging, 30, 466-473.
33. Langub, M.C., Herman, J.P., Malluche, H.H. & Koszewski, N.J. (2001) Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience, 104, 49-56.
34. Lehmann, D.J., Refsum, H., Warden, D.R., Medway, C., Wilcock, G.K. & Smith, A.D. (2011) The vitamin D receptor gene is associated with Alzheimer's disease. Neurosci. Lett., 504, 79-82.
35. Llewellyn, D.J., Lang, I.A., Langa, K.M., Muniz-Terrera, G., Phillips, C.L., Cherubini, A., Ferrucci, L. & Melzer, D. (2010) Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med., 170, 1135-1141.
36. Llewellyn, D.J., Langa, K.M. & Lang, I.A. (2009) Serum 25-hydroxyvitamin D concentration and cognitive impairment. J. Geriatr. Psychiatry Neurol., 22, 188-195.
37. Luedecking-Zimmer, E., DeKosky, S., Nebes, R. & Kamboh, I. (2003) Association of the 3'UTR transcription factor LBP-1c/CP2/LSF polymorphism with late-onset Alzheimer's disease. Am. J. Med. Gene B Neuropsychiatr. Genet., 117, 114-117.
38. Luine, V., Sonnenberg, J. & Christakos, S. (1987) Vitamin D: is the brain a target? Steroids, 49, 133-153.
39. Masoumi, A., Goldenson, B., Ghirmai, S., Avagyan, H., Zaghi, J., Abel, K., Zheng, X., Espinosa-Jeffrey, A., Mahanian, M., Liu, P.T., Hewison, M., Mizwickie, M., Cashman, J. & Fiala, M. (2009) 1alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J. Alzheimers Dis., 17, 703-717.
40. McCann, J. & Ames, B.N. (2008) Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J., 22, 982-1001.
41. Miller, W.L. & Portale, A.A. (2000) Vitamin D 1 alphahydroxylase. Trends Endocrinol. Metab., 11, 315-319.
42. Mizwicki, M.T., Menegaz, D., Zhang, J., Barrientos-Durán, A., Tse, S., Cashman, J.R., Griffin, P.R. & Fiala, M. (2012) Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages. J. Alzheimers Dis., 29, 51-62.
43. Musiol, I.M., Stumpf, W.E., Bidmon, H.J., Heiss, C., Mayerhofer, A. & Bartke, A. (1992) Vitamin D nuclear binding to neurons of the septal, substriatal and amygdaloid area in the Siberian hamster (Phodopus sungorus) brain. Neuroscience, 48, 841-848.
44. Oudshoorn, C., Mattace-Raso, F.U.S., van der Velde, N., Colin, E.M. & van der Cammen, T.J.M. (2008) Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with alzheimer's disease. Dement. Geriatr. Cogn. Disord., 25, 539-543.
45. Poduslo, S.E. & Yin, X. (2001) Chromosome 12 and late onset Alzheimer's disease. Neurosci. Lett., 310, 188-190.
46. Prufer, K., Veenstra, T.D., Jirikowski, G.F. & Kumar, R. (1999) Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J. Chem. Neuroanat., 16, 135-145.
47. Rocca, W.A., Hofmann, A., Brayne, C., Breteler, M.M., Clarke, M., Copeland, J.R., Dartigues, J.F., Engedal, K., Hagnell, O. & Heeren, T.J. (1991) Frequency and distribution of Alzheimer's Disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalance Research Group. Ann. Neurol., 30, 381-390.
48. Tuszynski, M.H., U, H.S., Alksne, J., Bakay, R.A., Pay, M.M., Merrill, D. & Thal, L.J. (2002) Growth factor gene therapy for Alzheimer disease. Neurosurg. Focus, 13, e5.
49. Uitterlinden, A.G., Fang, Y., Van Meurs, J.B., Pols, H.A. & Van Leeuwen, J.P. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene, 338, 143-156.
50. Veenstra, T.D., Prufer, K., Koenigsberger, C., Brimijoin, S.W., Grande, J.P. & Kumar, R. (1998) 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res., 804, 193-205.
51. Wilkins, C.H., Sheline, Y.I., Roe, C.M., Birge, S.J. & Morris, J.C. (2006) Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am. J. Geriat. Psychiatry, 14, 1032-1040.
52. Yu, J., Gattoni-Celli, M., Zhu, H., Bhat, N.R., Sambamurti, K., Gattoni-Celli, S. & Kindy, M.S. (2011) Vitamin D3-enriched diet correlates with a decrease of amyloid plaques in the brain of AβPP transgenic mice. J. Alzheimers Dis., 25, 295-307.